Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 5, keine Gesamtzahl für „multi“
Suchtreffer
Begriffe & Kennungen
Brilique · 4.8 · The bleeding profile of ticagrelor 60 mg was consistent across multiple pre-defined subgroups (e.g. by age, ge
Eintrag öffnenBrilique · 4.8 · The bleeding profile of ticagrelor 60 mg was consistent across multiple pre-defined subgroups (e.g. by age, ge
Eintrag öffnenBrintellix · 4.5 · Acetylsalicylic acid No effect of multiple doses of acetylsalicylic acid 150 mg/day on the multiple-dose pharm
Eintrag öffnenBrintellix · 4.5 · Acetylsalicylic acid No effect of multiple doses of acetylsalicylic acid 150 mg/day on the multiple-dose pharm
Eintrag öffnenBrintellix · 4.5 · Following multiple doses of vortioxetine, no inhibitory effect was observed in healthy subjects for the cytoch
Eintrag öffnenBrintellix · 4.5 · Following multiple doses of vortioxetine, no inhibitory effect was observed in healthy subjects for the cytoch
Eintrag öffnenBrintellix · 4.5 · No inhibitory effect of 40 mg single-dose omeprazole (CYP2C19 inhibitor) was observed on the multiple-dose pha
Eintrag öffnenBrintellix · 4.5 · No inhibitory effect of 40 mg single-dose omeprazole (CYP2C19 inhibitor) was observed on the multiple-dose pha
Eintrag öffnenBrukinsa · 4.5 · Co-administration of multiple doses of rifampicin (strong CYP3A inducer) decreased zanubrutinib Cmax by 92% an
Eintrag öffnenBrukinsa · 4.5 · Co-administration of multiple doses of rifampicin (strong CYP3A inducer) decreased zanubrutinib Cmax by 92% an
Eintrag öffnenBrukinsa · 4.5 · Co-administration of multiple doses of zanubrutinib decreased midazolam (CYP3A substrate) Cmax by 30% and AUC
Eintrag öffnenBrukinsa · 4.5 · Co-administration of multiple doses of zanubrutinib decreased midazolam (CYP3A substrate) Cmax by 30% and AUC
Eintrag öffnenBrukinsa · 4.5 · Co-administration of multiple doses of zanubrutinib decreased omeprazole (CYP2C19 substrate) Cmax by 20% and A
Eintrag öffnenBrukinsa · 4.5 · Co-administration of multiple doses of zanubrutinib decreased omeprazole (CYP2C19 substrate) Cmax by 20% and A
Eintrag öffnenBrukinsa · 4.5 · Co-administration of multiple doses of zanubrutinib increased digoxin (P-gp substrate) Cmax by 34% and AUC by
Eintrag öffnenBrukinsa · 4.5 · Co-administration of multiple doses of zanubrutinib increased digoxin (P-gp substrate) Cmax by 34% and AUC by
Eintrag öffnenBrukinsa · 4.5 · The coadministration of multiple doses of itraconazole (strong CYP3A inhibitor) in healthy volunteers increase
Eintrag öffnenBrukinsa · 4.5 · The coadministration of multiple doses of itraconazole (strong CYP3A inhibitor) in healthy volunteers increase
Eintrag öffnenBrukinsa · 4.5 · The coadministration of multiple doses of moderate CYP3A inhibitors fluconazole and diltiazem in patients with
Eintrag öffnenBrukinsa · 4.5 · The coadministration of multiple doses of moderate CYP3A inhibitors fluconazole and diltiazem in patients with
Eintrag öffnen